It was observed that patients with tumours harbouring ALK-rearrangements, EGFR and BRAF-mutations had indoor radon levels above the WHO recommendation of 100 Bq/m3, particularly for ALK-rearrangement. This evidence concerns the gene ALK and neoplasm.